Trospium Chloride Tablet, Film Coated
Product Images NDC 71610-812

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 71610-812). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 01)

FDA Label Image

Figure 1 (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 02)

Figure 1 (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 02)
This description provides data on plasma concentration (ng/mL) over time (hours post-dose), with time points at 0, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44, 46, and 48 hours.*
FDA Label Image

Figure 2 (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 03)

Figure 2 (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 03)
This is a statistical evaluation comparing the mean change in a certain measure between two groups (placebo and trospium chloride) after 12 weeks of treatment. The results indicate a significant difference (p<0.001) between the two groups. The sample sizes for the placebo and trospium chloride groups are 256 and 253, respectively.*
FDA Label Image

Figure 3 (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 04)

Figure 3 (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 04)
This text provides statistical information on the mean change in a particular variable between two treatment groups, namely placebo (n=2) and trospium chloride (n=253), with a significant p-value of 0.012. The data pertains to the effect of treatment over a specific time period.*
FDA Label Image

Figure 4 (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 05)

FDA Label Image

Figure 5 (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 06)

Figure 5 (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 06)
MEAN (+ SE) CHANGE in TROSPIUM CHLORIDE compared to PLACEBO at 12 weeks of treatment. Statistically significant difference shown with p<0.001.*
FDA Label Image

Image (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 07)

FDA Label Image

Image (0f16a8b8 Be7f 41e6 A5ca C97aba610d43 08)

FDA Label Image

Label (71610 812 87)

FDA Label Image

Aphena (Aphena)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.